http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1132905-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 |
filingDate | 1981-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1982-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60f7faf6c036a300eea1d1f99b58da57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7ce06a61322ecd8f05a5a29aeb69291 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49e1c4a3dc1ee382f5d9f60bf34cb937 |
publicationDate | 1982-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-1132905-A |
titleOfInvention | Antibiotic compositions |
abstract | ABSTRACT A vacuum sealed vial, which contains a solid antibiotic composition comprising 7.beta.-[2-(2-imino-4-thiazolin -4-yl)acetamido]-3-{1-[2-(N,N-dimethylam-ino)ethyl]-1H-tetrazol-5-yl}thiomethyl-3-cephem-4-carboxylic acid dihydrochloride or its hydrate and a pharmaceutically acceptable carbonic acid salt, the ratio of the hydrogen chloride moiety of 7.beta.[2-(2-imino-4-thiazoline-4-yl)acetamido]-3-{1-[2-(N,N-dimethylamino)ethyl]-1H-tetrazol-5-yl}thiomethyl-3-cephem-4-carboxylic acid dihydrochloride or its hydrate relative to the pharmaceutically acceptable carbonic acid salt being substantially 1:1 to 2 equivalents, the pressure in the vial being in the range of from 0 to 300 mm Hg. |
priorityDate | 1976-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.